CRISPR Therapeutics stockCRSP
CRISPR Therapeutics trades at $48.56, 23.5% below its 52-week high (Jul 6, 2026). The price is below its 50- and 200-day averages, a downtrend. −7.4% year to date, −14.8% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 16, 2027.
Ratings, candles, signals and the screener for CRSP — after you log in
Open the terminalFrequently asked questions about CRISPR Therapeutics
What is the CRISPR Therapeutics stock price?
At the close on Nov 5, 2026: $48.56 (−6.21% on the day). 52-week high: $63.45 on Jul 6, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does CRISPR Therapeutics report earnings?
The next quarterly report is on Feb 16, 2027. Last quarter, earnings per share changed +2% year over year, revenue +1,325%.
Does CRISPR Therapeutics pay dividends?
No, CRISPR Therapeutics does not pay dividends.
Where does CRISPR Therapeutics trade and how to buy it?
Ticker CRSP, exchange Nasdaq, listed since 2016. You can buy it through a broker with access to US exchanges.
Should I buy CRISPR Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for CRSP are in the terminal after you log in.